drugset / Trial / NCT00389324
A Trial of the Pharmacokinetics, Safety, and Tolerability of Subcutaneous Gamunex® in Primary Immunodeficiency
Non-randomizedCrossoverOpen-labelTreatment
Summary
This study will compare the blood level of Gamunex in patients. Patients will take it as an injection under the skin or in a vein. The study will compare how safe and tolerable the two methods are in the patients. The patients in this study have a defect in their immune system from a genetic cause.
Timeline
- Start
- 2006-11
- Primary completion
- 2008-08
- Completion
- 2008-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Immune Globulin Intravenous (Human) | Protein / enzyme biologic | 200 mg | Intravenous |
| Subject | Immune Globulin Intravenous (Human) | Protein / enzyme biologic | 600 mg | Intravenous |